Exousia Bio, Inc.
LMMY· OTC
LMMYExousia Bio, Inc.
Filed Jan 16, 2024 · 10-Q · 47 days after period end · 0001683168-24-000299
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Revenue | $3.88K | $0.00 |
| Net Income | -$3.57K | -$8.41K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Exousia Bio, Inc. · CIK 1939937 · Engraved from SEC EDGAR
ended Nov 30, 2023 · filed Jan 16, 2024 · 47 d after period end
